U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. RIXUBIS
  1. Approved Blood Products

STN: BL 125446
Proper Name: Coagulation Factor IX (Recombinant)
Tradename: RIXUBIS
Mannufacturer: Baxter Healthcare Corporation, License #140
Indication:

  • For adults and children with Hemophilia B for (1) control and prevention of bleeding episodes, (2) perioperative management, and (3) routine prophylaxis. 

Product Information

Supporting Documents

Back to Top